Skip to content

Outcomes in CF Patients Accessing Their Registry Health Records

Evaluating Outcomes in European Cystic Fibrosis Patients With Access to Their Health Records: a Randomised Control Trial of a Registry Patient Portal

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03434886
Acronym
CFView
Enrollment
282
Registered
2018-02-15
Start date
2016-03-31
Completion date
2017-09-30
Last updated
2018-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cystic Fibrosis

Brief summary

A multifactorial, parallel group, randomised control study in cystic fibrosis (CF) patients aged 13-30 years over an 18 month period. Patients will be offered read-only access to their CF registry electronic health record (CF View), or educational videos on CF (videos), or videos and CF View, or usual standard of care. The study aims are to examine the effect of patient access to C View on a range of clinical outcomes, health service usage, health literacy and patient reported outcomes.

Interventions

OTHERCFView

Registry patient portal

OTHERCF educational videos

CF educational videos

Sponsors

Cystic Fibrosis Registry of Ireland
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
13 Years to 30 Years
Healthy volunteers
No

Inclusion criteria

* diagnosed with CF * registered with their national CF patient registry * FEV1pp ≥40 * aged 13-30 years

Exclusion criteria

* organ transplantation * FEV1pp \<40

Design outcomes

Primary

MeasureTime frameDescription
FEV1pp18 monthsforced expiratory volume in 1 second percentage predicted

Secondary

MeasureTime frameDescription
Health literacy12 monthsHealth Literacy Survey - HLS- EU - Q16 score
Health-related quality of life12 monthsCFQr score - (Cystic Fibrosis questionnaire revised)
BMI18 monthskg/m\^2
Pulmonary exacerbations18 monthspulmonary exacerbation requiring IV antibiotics
Hospitalisations18 monthshospitalisation for treatment of pulmonary exacerbation

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026